Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax in Antibody Deficient Patients
NCT02960399Terminated
- Sponsor
- University of South Florida
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label trial of zoster vaccine, live in herpes zoster (HZ) (2 arms), sponsored by University of South Florida. Primary endpoint: In vitro changes in T cell proliferation at 6 months. Started Dec 2015; status: terminated.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02960399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960399.